HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ali Badiee Selected Research

Peptides (Polypeptides)

1/2021Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy.
8/2020Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy.
1/2020Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma.
1/2020Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.
12/2019P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer.
10/2019MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer.
1/2019Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system.
10/2018Preparation of nanoliposomes linked to HER2/neu-derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer.
1/2018Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice.
1/2018A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ali Badiee Research Topics

Disease

37Neoplasms (Cancer)
01/2022 - 12/2013
21Leishmaniasis
02/2021 - 08/2007
18Breast Neoplasms (Breast Cancer)
12/2021 - 01/2014
8Melanoma (Melanoma, Malignant)
10/2021 - 12/2015
8Carcinoma (Carcinomatosis)
08/2019 - 12/2013
7Infections
06/2020 - 08/2007
5Cutaneous Leishmaniasis
08/2019 - 07/2012
4Atherosclerosis
04/2020 - 07/2016
2Autoimmune Diseases (Autoimmune Disease)
12/2021 - 11/2021
2Tuberculosis (Tuberculoses)
06/2020 - 12/2019
2Dyslipidemias (Dyslipidemia)
12/2019 - 05/2015
2Dehydration (Water Stress)
04/2009 - 08/2007
1Multiple Sclerosis
12/2021
1Triple Negative Breast Neoplasms
11/2021
1Colonic Neoplasms (Colon Cancer)
01/2021
1Hypercholesterolemia
12/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Tetanus
01/2019
1Pulmonary Tuberculosis
01/2019
1Human Influenza (Influenza)
01/2018
1Hyperthermia
01/2017

Drug/Important Bio-Agent (IBA)

40VaccinesIBA
09/2021 - 04/2008
37Liposomes (Liposome)IBA
01/2022 - 08/2007
25AntigensIBA
11/2021 - 08/2007
23Peptides (Polypeptides)IBA
01/2021 - 12/2013
7liposomal doxorubicin (Doxil)FDA Link
11/2021 - 12/2013
7CPG-oligonucleotideIBA
01/2021 - 08/2007
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 12/2013
6Therapeutic UsesIBA
11/2021 - 04/2015
61,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
02/2021 - 12/2013
6Proteins (Proteins, Gene)FDA Link
12/2019 - 07/2012
5OligodeoxyribonucleotidesIBA
07/2018 - 04/2008
4LigandsIBA
12/2021 - 12/2013
4EnzymesIBA
10/2021 - 11/2014
4LipidsIBA
02/2021 - 01/2018
4Phospholipids (Phosphatides)FDA LinkGeneric
08/2019 - 11/2009
3Monoclonal AntibodiesIBA
08/2020 - 11/2015
3CholesterolIBA
04/2020 - 11/2014
3Pharmaceutical PreparationsIBA
01/2019 - 03/2016
3human ERBB2 proteinIBA
10/2018 - 06/2015
3Cisplatin (Platino)FDA LinkGeneric
01/2017 - 10/2014
2bis(p-chlorophenyl)acetic acid (DDA)IBA
01/2022 - 12/2019
2Cholesterol Ester Transfer ProteinsIBA
04/2020 - 07/2016
2BuffersIBA
04/2020 - 12/2016
2AntibodiesIBA
12/2019 - 11/2015
2BCG VaccineFDA Link
12/2019 - 01/2019
2distearoyl phosphatidylglycerol (DSPG)IBA
08/2019 - 01/2018
21,2-distearoylphosphatidylethanolamine (DSPE)IBA
08/2019 - 01/2017
2miltefosine (Impavido)IBA
08/2019 - 12/2015
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019 - 05/2015
2Leishmaniasis VaccinesIBA
12/2018 - 01/2013
2ChitosanIBA
12/2018 - 01/2018
2Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2018 - 12/2012
2ISCOMATRIXIBA
01/2018 - 02/2016
2Tetanus Toxoid (Vaccine, Tetanus)FDA Link
12/2016 - 07/2016
21-dodecylpyridoxal (PLD)IBA
05/2016 - 12/2013
2Nucleotide AptamersIBA
03/2016 - 06/2015
2EpitopesIBA
01/2016 - 01/2014
2cyclic arginine-glycine-aspartic acid peptideIBA
12/2015 - 12/2013
2arginyl-glycyl-aspartic acidIBA
12/2015 - 12/2013
2IntegrinsIBA
12/2015 - 12/2013
2CytokinesIBA
05/2015 - 11/2014
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
11/2014 - 12/2013
1Silybin (Lagosa)IBA
12/2021
1Biological ProductsIBA
12/2021
1Lapatinib (GW572016)FDA Link
11/2021
1Tryptophan (L-Tryptophan)FDA Link
10/2021
1Cancer VaccinesIBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1Nanoparticle Drug Delivery SystemIBA
11/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020
1Glutathione (Reduced Glutathione)IBA
11/2020
1NanovaccinesIBA
08/2020
1Combined VaccinesIBA
08/2020
1DNA VaccinesIBA
06/2020
1CurcuminIBA
04/2020
1Histocompatibility Antigens Class IIBA
01/2020
1dimyristoylphosphatidylglycerol (DMPG)IBA
08/2019
1Dimyristoylphosphatidylcholine (DMPC)IBA
08/2019
1Oxidoreductases (Dehydrogenase)IBA
01/2019
1Protein Subunit VaccinesIBA
01/2019
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
01/2019
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2019
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
01/2019
1monophosphoryl lipid AIBA
10/2018
1dioleoyl phosphatidylethanolamineIBA
10/2018
1InterferonsIBA
10/2018
1Vaccine AdjuvantsIBA
07/2018
1ArginaseIBA
07/2018
1Immunoglobulin G (IgG)IBA
02/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1invariant chain (Ii-Key)IBA
01/2018
11,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)IBA
01/2017
1MF59 oil emulsionIBA
12/2016
1aluminum sulfate (alum)IBA
12/2016
1Bovine Serum AlbuminIBA
03/2016

Therapy/Procedure

10Therapeutics
01/2022 - 04/2015
6Immunotherapy
11/2021 - 05/2015
2Subcutaneous Injections
05/2015 - 11/2014
2Fluid Therapy (Oral Rehydration Therapy)
04/2009 - 08/2007